Pharmion upgraded to "buy"

09/25/06 - Lazard Capital Markets

NEW YORK, September 25 (newratings.com) - Analysts at Lazard Captial upgrade Pharmion Corporation (PHRM) from "hold" to "buy." The target price is set to $28.